Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: Evidence from pubertal mouse models

Journal of Bone and Mineral Research

Volumn 25, Issue 3, 2010, Pages 617-626

  Callewaert, Filip ^a   Venken, Katrien ^a   Kopchick, John J ^b   Torcasio, Antonia ^a   Van Lenthe, G Harry ^a   Boonen, Steven ^a   Vanderschueren, Dirk ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b OHIO UNIVERSITY   (United States)

Author keywords

Androgens; Body weight gain; Estrogens; GH IGF 1; Skeletal dimorphism

Indexed keywords

ANDROGEN; ESTROGEN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SEX HORMONE; SOMATOMEDIN; SOMATOMEDIN C;

ANDROGEN DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE STRENGTH; CONTROLLED STUDY; CORTICAL BONE; ESTROGEN DEFICIENCY; FEMALE; MALE; MOUSE; NONHUMAN; ORCHIECTOMY; OSSIFICATION; OVARIECTOMY; PERIOSTEUM; PUBERTY; RADIUS; SEX DIFFERENCE; SEX RATIO; SKELETON; ANATOMY AND HISTOLOGY; ANIMAL; ANIMAL MODEL; BIOMECHANICS; BODY WEIGHT; BONE; C57BL MOUSE; FEMUR; HUMAN; LONGITUDINAL STUDY; METABOLISM; ORGAN SIZE; PHYSIOLOGY; SEXUAL MATURATION; SHEAR STRENGTH; TIBIA; TIME;

ANDROGENS; ANIMALS; BIOMECHANICAL PHENOMENA; BODY WEIGHT; BONE AND BONES; BONE DENSITY; ESTROGENS; FEMALE; FEMUR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; ORGAN SIZE; SEX FACTORS; SEXUAL MATURATION; SHEAR STRENGTH; TIBIA; TIME FACTORS;

EID: 77953471006     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090828     Document Type: Article

References (49)

1. Saggese G, Baroncelli GI, Bertelloni S. Puberty and bone development. Best Pract Res Clin Endocrinol Metab. 2002;16:53-64.
2. Riggs BL, Khosla S, Melton LJ 3rd., The assembly of the adult skeleton during growth and maturation: implications for senile osteoporosis. J Clin Invest. 1999;104:671-672. (Pubitemid 29536349)
3. Seeman E. Clinical review 137: Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab. 2001;86:4576-4584. (Pubitemid 33020488)
4. Seeman E. Pathogenesis of bone fragility in women and men. Lancet. 2002;359:1841-1850. (Pubitemid 34607063)
5. Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev. 2008;29:441-464.
6. Finkelstein JS, Klibanski A, Neer RM, et al. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1989;69:776-783. (Pubitemid 19245856)
7. Marcus R, Leary D, Schneider DL, Shane E, Favus M, Quigley CA. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. J Clin Endocrinol Metab. 2000;85:1032-1037. (Pubitemid 32269345)
8. Smith EP, Specker B, Bachrach BE, et al. Impact on bone of an estrogen receptor-alpha gene loss of function mutation. J Clin Endocrinol Metab. 2008;93:3088-3096.
9. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331:1056-1061. (Pubitemid 24317698)
10. Bouillon R, Bex M, Vanderschueren D, Boonen S. Estrogens are essential for male pubertal periosteal bone expansion. J Clin Endocrinol Metab. 2004;89:6025-6029. (Pubitemid 39628410)
11. Callewaert F, Venken K, Ophoff J, et al. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha. FASEB J. 2009;23:232-240.
12. Sims NA, Clement-Lacroix P, Minet D, et al. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest. 2003;111:1319-1327. (Pubitemid 36554702)
13. Venken K, De Gendt K, Boonen S, et al. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J Bone Miner Res. 2006;21:576-585.
14. Zhou Y, Xu BC, Maheshwari HG, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA. 1997;94:13215-13220. (Pubitemid 27518502)
15. Sjogren K, Bohlooly YM, Olsson B, et al. Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. Biochem Biophys Res Commun. 2000; 267:603-608.
16. Sims NA, Clement-Lacroix P, Da Ponte F, et al. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-1 but independent of Stat5. J Clin Invest. 2000;106:1095-1103.
17. Bachrach LK, Marcus R, Ott SM, et al. Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency. J Bone Miner Res. 1998;13:415-421. (Pubitemid 28146224)
18. Bikle D, Majumdar S, Laib A, et al. The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res. 2001;16: 2320-2329. (Pubitemid 33104725)
19. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol. 2001;229:141-162. (Pubitemid 32061720)
20. Venken K, Schuit F, Van Lommel L, et al. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic insulin-like growth factor-I synthesis. J Bone Miner Res. 2005;20:2138-2149. (Pubitemid 41698777)
21. Chandrashekar V, Bartke A, Coschigano KT, Kopchick JJ. Pituitary and testicular function in growth hormone receptor gene knockout mice. Endocrinology. 1999;140:1082-1088. (Pubitemid 29104206)
22. Dukes M, Edwards PN, Large M, Smith IK, Boyle T. The preclinical pharmacology of "Arimidex" (anastrozole, ZD1033): a potent, selective aromatase inhibitor. J Steroid Biochem Mol Biol. 1996;58:439-445.
23. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
24. Verhaeghe J, van Herck E, Visser WJ, et al. Bone and mineral metabolism in BB rats with long-term diabetes: decreased bone turnover and osteoporosis. Diabetes. 1990;39:477-482. (Pubitemid 20111432)
25. Tanner JM, Whitehouse RH, Marubini E, Resele LF. The adolescent growth spurt of boys and girls of the Harpenden growth study. Ann Hum Biol. 1976;3:109-126.
26. Venken K, Moverare-Skrtic S, Kopchick JJ, et al. Impact of androgens, growth hormone, and IGF-I on bone and muscle in male mice during puberty. J Bone Miner Res. 2007;22:72-82. (Pubitemid 46032599)
27. Jansson JO, Eden S, Isaksson O. Sexual dimorphism in the control of growth hormone secretion. Endocr Rev. 1985;6:128-150.
28. Millard WJ, Politch JA, Martin JB, Fox TO. Growth hormone-secretory patterns in androgen-resistant (testicular feminized) rats. Endocrinology. 1986;119:2655-2660.
29. Udy GB, Towers RP, Snell RG, et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA. 1997;94:7239-7244.
30. Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E. The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest. 1999;104:795-804. (Pubitemid 29536365)
31. Bradney M, Karlsson MK, Duan Y, Stuckey S, Bass S, Seeman E. Heterogeneity in the growth of the axial and appendicular skeleton in boys: implications for the pathogenesis of bone fragility in men. J Bone Miner Res. 2000;15:1871-1878.
32. Schoenau E, Neu CM, Mokov E, Wassmer G, Manz F. Influence of puberty on muscle area and cortical bone area of the forearm in boys and girls. J Clin Endocrinol Metab. 2000;85:1095-1098. (Pubitemid 32269355)
33. Zhang XZ, Kalu DN, Erbas B, Hopper JL, Seeman E. The effects of gonadectomy on bone size, mass, and volumetric density in growing rats are gender-, site-, and growth hormone-specific. J Bone Miner Res. 1999;14:802-809. (Pubitemid 29210607)
34. Frost HM. Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol. 2003;275:1081-1101.
35. Frost HM. Bone "mass" and the "mechanostat": a proposal. Anat Rec. 1987;219:1-9.
36. Labrie F. Intracrinology. Mol Cell Endocrinol. 1991;78:C113-118.
37. van Weerden WM, Bierings HG, van Steenbrugge GJ, de Jong FH, Schroder FH. Adrenal glands of mouse and rat do not synthesize androgens. Life Sci. 1992;50:857-861.
38. Matsumoto C, Inada M, Toda K, Miyaura C. Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity. Bone. 2006;38:220-226. (Pubitemid 43165788)
39. Vanderschueren D, van Herck E, Nijs J, Ederveen AG, De Coster R, Bouillon R. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology. 1997;138:2301-2307. (Pubitemid 27215229)
40. Juul A. The effects of oestrogens on linear bone growth. Hum Reprod Update. 2001;7:303-313. (Pubitemid 32440292)
41. Bartke A, Steele RE, Musto N, Caldwell BV. Fluctuations in plasma testosterone levels in adult male rats and mice. Endocrinology. 1973;92:1223-1228.
42. Coquelin A, Desjardins C. Luteinizing hormone and testosterone secretion in young and old male mice. Am J Physiol. 1982;243: E257-263. (Pubitemid 12006832)
43. Richmond EJ, Rogol AD. Male pubertal development and the role of androgen therapy. Nat Clin Pract Endocrinol Metab. 2007;3:338-344. (Pubitemid 46474646)
44. Rogol AD, Roemmich JN, Clark PA. Growth at puberty. J Adolesc Health. 2002;31:192-200.
45. Jean-Faucher C, Berger M, de Turckheim M, Veyssiere G, Jean C. Developmental patterns of plasma and testicular testosterone in mice from birth to adulthood. Acta Endocrinol (Copenh.) 1978;89:780-788. (Pubitemid 9062057)
46. Selmanoff MK, Goldman BD, Ginsburg BE. Developmental changes in serum luteinizing hormone, follicle stimulating hormone and androgen levels in males of two inbred mouse strains. Endocrinology. 1977;100:122-127.
47. Potau N, Ibanez L, Sentis M, Carrascosa A. Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge. Eur J Endocrinol. 1999;141:27-34. (Pubitemid 29370834)
48. Kirmani S, Christen D, van Lenthe GH, et al. Bone structure at the distal radius during adolescent growth. J Bone Miner Res. 2009;24:1033-1042.
49. Leger J, Mercat I, Alberti C, et al. The relationship between the GH/ IGF-I axis and serum markers of bone turnover metabolism in healthy children. Eur J Endocrinol. 2007;157:685-692. (Pubitemid 350187387)